高级检索

Knops血型系统抗原研究进展

,  ,  ,  , 

上一篇

下一篇

文章导航 > 临床血液学杂志 > 2020 > 33(8): 582-588
王晓宁, 李树中, 李中华, 等. Knops血型系统抗原研究进展[J]. 临床血液学杂志, 2020, 33(8): 582-588. doi: 10.13201/j.issn.1004-2806-b.2020.08.017
引用本文: 王晓宁, 李树中, 李中华, 等. Knops血型系统抗原研究进展[J]. 临床血液学杂志, 2020, 33(8): 582-588. doi: 10.13201/j.issn.1004-2806-b.2020.08.017
shu
WANG Xiaoning, LI Shuzhong, LI Zhonghua, et al. Advances in research on Knops blood group system antigen[J]. J Clin Hematol, 2020, 33(8): 582-588. doi: 10.13201/j.issn.1004-2806-b.2020.08.017
Citation: WANG Xiaoning, LI Shuzhong, LI Zhonghua, et al. Advances in research on Knops blood group system antigen[J]. J Clin Hematol, 2020, 33(8): 582-588. doi: 10.13201/j.issn.1004-2806-b.2020.08.017
shu

Knops血型系统抗原研究进展

    • 1 吉林大学第一医院输血科(长春, 130021);

    • 2 江苏大学附属昆山医院;

    • 3 黑龙江省牡丹江市第二人民医院;

    • 4 长春博迅生物技术有限责任公司;

    • 5 四川省洪雅县妇幼保健计划生育服务中心

详细信息

  • 中图分类号: R457.11

Advances in research on Knops blood group system antigen

    摘要
  • The gene of Knops antigen has 39 exons.The encoded product Kn antigen glycoprotein is composed of 1 920 amino acids.It is a complement C3b/C4b receptor,also known as complement type I receptor (CR1), which belongs to membrane differentiation antigen CD35.It is one of the important components of the immune mechanism.Among them,1 792 amino acids constitute 4 long homologous repeats,and Kn antigens are expressed in the 4th sequence (LHR-D). Kn antigen is associated with malaria parasite infection,leishmaniasis,bacterial infection,and insulin-dependent diabetes,malignant tumor,and AIDS.
    • HTML全文
  • 加载中
    • 参考文献(35)
  • [1]

    Brekke OL,Christiansen D,Kisserli A,et al.Key role of the number of complement receptor 1 on erythrocytes for binding of Escherichia coli to erythrocytes and for leukocyte phagocytosis and oxidative burst in human whole blood[J].Mol Immunol,2019,114:139-148.

    [2]

    Mácsik-Valent B,Nagy K,Fazekas L,et al.Complement Receptor Type 1(CR1,CD35),the Inhibitor of BCR-Mediated Human B Cell Activation,Differentially Regulates TLR7,and TLR9 Induced Responses[J].Front Immunol,2019,10:1493.

    [3]

    Covas DT,de Oliveira FS,Rodrigues ES,et al.Knops blood group haplotypes among distinct Brazilian populations[J].Transfusion,2007,47:147-153.

    [4]

    Luo J,Chen S,Wang J,et al.Genetic polymorphisms in complement receptor 1 gene and its association with HBV-related liver disease:A case-control study[J].Gene,2019,688:107-118.

    [5]

    Kretzschmar GC,Oliveira LC,Nisihara RM,et al.Complement receptor 1(CR1,CD35)association with susceptibility to leprosy[J].PLoS Negl Trop Dis,201812:e0006705.

    [6]

    Jacquet M,Cioci G,Fouet G,et al.C1q and Mannose-Binding Lectin Interact with CR1 in the Same Region on CCP24-25 Modules[J].Front Immunol,20189:453.

    [7]

    Sandri TL,Lidani KCF,Andrade FA,et al.Human complement receptor type 1(CR1)protein levels and genetic variants in chronic Chagas Disease[J].Sci Rep,2018,8:526.

    [8]

    Swann OV,Harrison EM,Opi DH,et al.No Evidence that Knops Blood Group Polymorphisms Affect Complement Receptor 1 Clustering on rythrocytes[J].Sci Rep,2017,7:17825.

    [9]

    Mahmoudi R,Feldman S,Kisserli A,et al.Inherited and Acquired Decrease in Complement Receptor 1(CR1)Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer's Disease[J].Int J Mol Sci,2018,19:pii:E2175.

    [10]

    Kucukkilic E,Brookes K,Barber I,et al.Complement receptor 1 gene(CR1)intragenic duplication and risk of Alzheimer's disease[J].Hum Genet,2018,37:305-314.

    [11]

    Hyakuna N,Hashii Y,Ishida H,et al.Retrospective analysis of children with high-risk acute myeloid leukemia who underwent allogeneic hematopoietic stem cell transplantation following complete remission with initial induction chemotherapy in the AML-05 clinical trial[J].Pediatr Blood Cancer,2019:e27875.

    [12]

    Prajapati SK,Borlon C,Rovira-Vallbona E,et al.Complement Receptor 1 availability on red blood cell surface modulates Plasmodium vivax invasion of human reticulocytes[J].Sci Rep,2019,9:8943.

    [13]

    Luo L,Fang S,Zhao S,et al.Haploidentical,Unmanipulated Granulocyte Colony-Stimulating Factor(G-CSF)-Primed Peripheral Blood Stem Cell Transplants for Acute Myeloid Leukemia(AML)in Remission:A Single Center Experience[J].Ann Transplant,2019,24:367-373.

    [14]

    Chijiwa T,Inamaru K,Takeuchi A,et al.Unique structure(construction and configuration)and evolution of the array of small serum protein genes of Protobothrops flavoviridis snake[J].Biosci Rep,2019,39:pii:BSR20190560.

    [15]

    Rashidi A,Hamadani M,Zhang MJ,et al.Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission[J].Blood Adv,2019,3:1826-1836.

    [16]

    Moulds JM.The Knops blood group system:a review[J].Immunohematology,2010,26:2-6.

    [17]

    Huang Y,Hu J,Lu T,et alAcute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis[J].Cancer Manag Res,2019,11:4129-4142.

    [18]

    Opi DH,Uyoga S,Orori EN,et al.Red blood cell complement receptor one level varies with Knops blood group,α(+)thalassaemia and age among Kenyan children[J].Genes Immun,2016,17:171-178.

    [19]

    Swann OV,Harrison EM,Opi DH,et al.No Evidence that Knops Blood Group Polymorphisms Affect Complement Receptor 1 Clustering on Erythrocytes[J].Sci Rep,2017,7:17825.

    [20]

    Opi DH,Swann O,Macharia A,et al.Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α+thalassaemia[J].Elife,2018,7:pii:e31579.

    [21]

    Jindra P,Raida L,Karas M,et al.Allogeneic Stem Cell Transplantation in Patients With FLT3-ITD Mutated AML:Transplantation in CR1 Is the Decisive Factor for Good Outcome[J].Clin Lymphoma Myeloma Leuk,2019,19:462-469.

    [22]

    Ustun C,Le-Rademacher J,Wang HL,et al.Allogeneic hematopoietic cell transplantation compared to chemotherapy consolidation in older acute myeloid leukemia(AML)patients 60-75 years in first complete remission(CR1):an alliance(A151509),SWOG,ECOG-ACRIN,and CIBMTR study[J].Leukemia,2019,33:2599-2609.

    [23]

    Lucas Sandri T,Adukpo S,Giang DP,et al.Geographical distribution of complement receptor type 1 variants and their associated disease risk[J].PLoS One,2017,12:e0175973.

    [24]

    opi DH,Uyoga S,Orori EN,et al.Red blood cell complement receptor one level varies with Knops blood group,α(+)thalassaemia and age among Kenyan children[J].Genes Immun,2016,17:171-178.

    [25]

    Duru KC,Noble JA,Guindo A,et al.Extensive genomic variability of knops blood group polymorphisms is associated with sickle cell disease in Africa[J].Evol Bioinform Online,2015,11:25-33.

    [26]

    Tettey R,Ayeh-Kumi P,Tettey P,et al.Severity of malaria in relation to a complement receptor 1 polymorphism:a case-control study[J].Pathog Glob Health,2015,109:247-252.

    [27]

    张志琴,李树中,谢怡萍,等.Duffy血型系统抗原研究进展[J].临床血液学杂志,2017,30(8):327-330.

    [28]

    倪强,李树中.GIL抗原研究进展[J].临床血液学杂志,2017,30(10):812-814.

    [29]

    黎娅,陆敏,李树中,等.VEL血型抗原研究进展[J].临床血液学杂志,2018,31(2):161-163.

    [30]

    刘芸,李树中,雒晶晶,等.AUG血型抗原研究进展[J].临床血液学杂志,2018,31(6)485-490.

    [31]

    范春丽,李树中,李中华,等.P1PK血型抗原研究进展[J].临床血液学杂志,2018,31(8)643-648.

    [32]

    张志琴,李树中,李中华,等.Duffy血型抗原的G-蛋白偶联受体作用[J].临床血液学杂志,2019,32(2):162-166.

    [33]

    徐姿,李树中,李中华,等.Junier抗原的最新研究进展[J].临床血液学杂志,2019,32(4):322-326.

    [34]

    王鹤,李树中,李中华,等.RHAG血型抗原研究进展[J].临床血液学杂志,2019,32(6):479-482.

    [35]

    叶小英,李树中,李中华,等.CD59-血型抗原的研究新进展[J].临床血液学杂志,2019,32(6):487-489.

    • 相关文章
  • 施引文献
  • 资源附件(0)
  • 加载中
计量
  • 文章访问数:  149
  • PDF下载数:  103
  • 施引文献:  0
出版历程
收稿日期:  2019-08-16

目录

    返回

    用微信扫描二维码

    分享至好友和朋友圈

    地址：

    邮政编码：

    电话：

    E-mail： lcxyxzz@whuh.com

    {{newsColumn.name}}

    {{news.title}}

    版权所有 © 武汉协和医院杂志社 鄂ICP备 05004666-1 技术支持： 北京仁和汇智信息技术有限公司